BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2420443)

  • 1. Treatment of metastatic malignant melanoma with vinblastine, dacarbazine, and cisplatin: a report from the Cancer and Leukemia Group B.
    Carey RW; Anderson JR; Green M; Ellison RR; Nathanson L; Kennedy BJ
    Cancer Treat Rep; 1986 Mar; 70(3):329-31. PubMed ID: 2420443
    [No Abstract]   [Full Text] [Related]  

  • 2. Cisplatin, vinblastine, and bleomycin in the treatment of metastatic melanoma: a phase II study of the Southeastern Cancer Study Group.
    Johnson DH; Presant C; Einhorn L; Bartolucci AA; Greco FA
    Cancer Treat Rep; 1985; 69(7-8):821-4. PubMed ID: 2410120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of vinblastine, bleomycin, and cisplatin (VBP) followed by dacarbazine and mitolactol in metastatic melanoma.
    Richman SP; Woodcock TM; Kubota TT; Blumenreich MS; Gentile PS; Allegra JC
    Cancer Treat Rep; 1984 Nov; 68(11):1395-6. PubMed ID: 6209008
    [No Abstract]   [Full Text] [Related]  

  • 4. Dacarbazine, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma: a phase II study.
    Gundersen S
    Cancer Treat Rep; 1987 Nov; 71(11):997-9. PubMed ID: 3677119
    [No Abstract]   [Full Text] [Related]  

  • 5. Lomustine, bleomycin, and cisplatin in patients with metastatic malignant melanoma.
    Cohen SM; Ohnuma T; Ambinder EP; Holland JF
    Cancer Treat Rep; 1986 May; 70(5):688-9. PubMed ID: 2423239
    [No Abstract]   [Full Text] [Related]  

  • 6. How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?
    Canellos GP; Duggan D; Johnson J; Niedzwiecki D
    J Clin Oncol; 2004 Apr; 22(8):1532-3. PubMed ID: 15084636
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of metastatic malignant melanoma with dacarbazine and cisplatin.
    Oratz R; Speyer JL; Green M; Blum R; Wernz JC; Muggia FM
    Cancer Treat Rep; 1987 Sep; 71(9):877-8. PubMed ID: 3621224
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of advanced malignant melanoma with vinblastine, bleomycin, and cisplatin.
    Bajetta E; Rovej R; Buzzoni R; Vaglini M; Bonadonna G
    Cancer Treat Rep; 1982 Jun; 66(6):1299-302. PubMed ID: 6177408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver metastases from uveal melanoma: clinical experience of hepatic arterial infusion of cisplatin, vinblastine and dacarbazine.
    Melichar B; Voboril Z; Lojík M; Krajina A
    Hepatogastroenterology; 2009; 56(93):1157-62. PubMed ID: 19760961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of metastatic malignant melanoma with vinblastine, bleomycin by infusion and cisplatin.
    York RM; Lawson DH; McKay J
    Cancer; 1983 Dec; 52(12):2220-2. PubMed ID: 6196103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic chemotherapy in the treatment of malignant melanoma.
    Lens MB; Eisen TG
    Expert Opin Pharmacother; 2003 Dec; 4(12):2205-11. PubMed ID: 14640919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected clinical outcome in a patient with liver and brain metastasis from melanoma.
    Nuzzo C; Zeuli M; Ferraresi V; Ciccarese M; Pelligrini D; Cognetti F
    Anticancer Res; 2008; 28(2B):1429-31. PubMed ID: 18505091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current results with surgery and adjuvant chemotherapy in malignant melanoma].
    Mechl Z; Kopecný J
    Arch Geschwulstforsch; 1986; 56(5):367-71. PubMed ID: 2429631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy for metastatic melanoma: effective combination of dacarbazine, carmustine, cisplatin and tamoxifen.
    Fierro MT; Bertero M; Novelli M; Appino A; Doveil GC; Colonna S; Bernengo MG
    Melanoma Res; 1993 Apr; 3(2):127-31. PubMed ID: 8518551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of the combination of vinblastine plus cisplatin administered by continuous 120-hour infusion for patients with advanced malignant melanoma.
    Creagan ET; Ahmann DL; Schutt AJ; Schaid DJ
    Cancer Treat Rep; 1987; 71(7-8):769-70. PubMed ID: 3607788
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine.
    Propper DJ; Braybrooke JP; Levitt NC; O'Byrne K; Christodoulos K; Han C; Talbot DC; Ganesan TS; Harris AL
    Br J Cancer; 2000 Jun; 82(11):1759-63. PubMed ID: 10839287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combination of dacarbazine, cisplatin and interferon alpha in the treatment of metastatic melanoma].
    Tessier MH; Mansat E; Legoux B; Litoux P; Dreno B
    Ann Dermatol Venereol; 1996; 123(9):538-42. PubMed ID: 9615103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy with dacarbazine and vindesine in the treatment of metastatic malignant melanoma.
    Vorobiof DA; Sarli R; Falkson G
    Cancer Treat Rep; 1986 Jul; 70(7):927-8. PubMed ID: 3719588
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma.
    Del Prete SA; Maurer LH; O'Donnell J; Forcier RJ; LeMarbre P
    Cancer Treat Rep; 1984 Nov; 68(11):1403-5. PubMed ID: 6541973
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chemotherapy of malignant melanoma].
    Ishihara K; Yamazaki N; Asano K
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1287-92. PubMed ID: 7688498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.